NICE guidelines for venous thromboembolism prophylaxis in hospitalized patients aim to reduce hospital-acquired VTE, which accounts for an estimated 25,000 deaths annually in England.
Does VTE prophylaxis prevent venous thromboembolism in patients admitted to hospital?
This article provides a summary of the updated NICE guidance for assessing VTE and bleeding risks and implementing thromboprophylaxis in hospitalized patients.
Of an estimated 25 000 deaths in England each year attributable to hospital acquired venous thromboemobolism (VTE), many are potentially preventable.1 2 Despite the substantial evidence base for the benefits of thromboprophylaxis this was used in only about half of eligible patients and many healthcare professionals seemed to be unaware of the risks.3 4 The National Institute for Health and Clinical Excellence (NICE) published guidance on the prevention of VTE for surgical patients in 2007.5 This article summarises the most recent recommendations from NICE on VTE prophylaxis for all patients in hospital. NICE recommendations are based on systematic reviews of best available evidence. When minimal evidence is available, recommendations are based on the Guideline Development Group’s experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets. (See further information box for a description of the evidence and challenges in formulating recommendations for this guidance.) ### Assessing the risks of VTE and bleeding #### Box 1 Risk factors for venous thromboembolism (VTE)
Hill et al. (Wed,) conducted a review in Venous thromboembolism. Venous thromboembolism prophylaxis was evaluated. NICE guidelines for venous thromboembolism prophylaxis in hospitalized patients aim to reduce hospital-acquired VTE, which accounts for an estimated 25,000 deaths annually in England.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: